Bone marrow transplantation versus chimeric antigen receptor T cells (CAR-T) therapy for hematological malignancies Arnon Nagler; on behalf of the Sheba Team;

HAPLOIDENTICAL VERSUS UNRELATED ALLOGENEIC STEM CELL TRANSPLANTATION FOR ADULTS WITH ACUTE LEUKEMIA Arnon Nagler;

Update on chimeric antigen receptor ¿ T cells (CAR-T) CD19 therapy: the Sheba experience Arnon Nagler;